Goserelin Suppliers and Product Information

Goserelin is a synthetic decapeptide ***ogue of luteinizing hormone-releasing hormone (LHRH). It is used in the treatment of prostate cancer, breast cancer, endometriosis, and uterine fibroids. The drug is administered parenterally in a biodegradable depot form.

Goserelin acts as an antineoplastic and antitumor agent. It is marketed under the brand name Zoladex by Zeneca. The drug works by suppressing the production of sex hormones, which can slow or stop the growth of certain types of cancer cells.

Frequently Asked Questions about Goserelin

Q: What is Goserelin used for?

A: Goserelin is primarily used to treat advanced prostate cancer, breast cancer, endometriosis, and for endometrial thinning. It's also used in the treatment of uterine fibroids.

Q: How is Goserelin administered?

A: Goserelin is administered parenterally (by injection) in a biodegradable depot form. It's typically given as a subcutaneous implant.

Q: What are the common side effects of Goserelin?

A: Common side effects may include hot flashes, flushing, dizziness, headache, increased sweating, decreased sexual interest/ability, trouble sleeping, nausea, changes in breast size, vaginal dryness, and hair loss. Pain, bruising, bleeding, redness, or swelling at the injection site may also occur.

Q: Are there any serious side effects to be aware of?

A: Serious side effects, though rare, can include symptoms of a heart attack, signs of a stroke, fast/irregular heartbeat, severe dizziness, and fainting. In men using this medication for prostate cancer, urinary blockage or spinal cord compression can occur, especially during the first month of treatment.

Q: How does Goserelin work?

A: Goserelin works by suppressing the production of sex hormones (*** in men and estrogen in women). This can slow or stop the growth of certain types of cancer cells that depend on these hormones for growth.